PPARA and breast cancer: In this context, three phenylsulfonimide derivatives targeting PPARα, namely IB42, IB44, and IB66, selected from a previous investigation [25], have been tested in vitro on human BC cells (MCF7 cell line) to verify their effectiveness as anti-proliferative and pro-apoptotic compounds.